-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

Benzinga·08/06/2026 18:56:22
Listen to the news
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.